CYNOSURE INC 4

4 · CYNOSURE INC · Filed May 16, 2016

Form 4

Period: 2016-05-12

Executive VP, CFO, Treasurer

Transactions

Exercise/Conversion
Class A Common Stock
2016-05-12$30.51/sh+2,042$62,301→ 2,042 total
Sale
Class A Common Stock
2016-05-12$46.24/sh−2,042$94,418→ 0 total
Sale
Class A Common Stock
2016-05-12$46.24/sh−4,576$211,584→ 5,000 total
Exercise/Conversion
Employee Stock Option (right to buy)
2016-05-12−2,042→ 14,292 total
Exercise: $30.51Exp: 2025-02-11→ Class A Common Stock (2,042 underlying)
Exercise/Conversion
Class A Common Stock
2016-05-13$29.40/sh+5,833$171,490→ 5,833 total
Sale
Class A Common Stock
2016-05-13$47.01/sh−5,833$274,184→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2016-05-13−5,833→ 17,501 total
Exercise: $29.40Exp: 2024-02-13→ Class A Common Stock (5,833 underlying)

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $45.29 to $47.61 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $46.29 to $47.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/11/2015 grant date.
[F5]The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/13/2014 grant date.

Documents

1 file